Impact BioMedical
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200 Canal View Blvd Ste 104, Rochester, ...Phone Number
(585) 232-1500Website
www.impbio.comRevenue
<$5 MillionStock Symbol
IBOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Impact BioMedical
Impact Biomedical is a research and development company that advances drug discovery and development for the prevention, inhibition, and treatment of neurological, oncology and immuno-related diseases. The company is based in Rochester, NY.Explore more
Impact BioMedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Impact BioMedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Impact BioMedical is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Impact BioMedical recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Impact BioMedical
Check if Impact BioMedical has recently received funding, and reach out quickly before it becomes old news!
Impact BioMedical, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Impact BioMedical has new funding data
Click to see if Impact BioMedical had a recent Job posting/layoffs
Product Launch: Get notified when Impact BioMedical launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Impact BioMedical
Compare insights from companies similar to Impact BioMedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Impact BioMedical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Impact BioMedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Impact BioMedical.
Impact BioMedical Tech Stack
A closer look at the technologies used by Impact BioMedical
Impact BioMedical News & Media
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical's initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness solutions, has set its IPO price at $3.00 per share, with an initial offering of 1,500,000 shares. Trading under the ticker symbol “IBO,” these shares will beginDSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
ROCHESTER, N.Y., June 30, 2023 -- DSS, Inc. , a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic...DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend
DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS ShareROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14,Impact Biomedical and Global Research and Discovery Group Announce the Completion of Phase One of The Bne-1 Cancer Suppression Monoclonal Antibody Project
MARCO ISLAND, Fla., Feb. 22, 2023 /PRNewswire/ -- In the fight against cancer, the next step could be evolutionary. Impact BioMedical and its research partner Global Research and Discovery Group today announced that they have finished the first phase of a groundbreaking project that could...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Impact BioMedical
Sign Up For FreeTo access detailed company insights
Impact Biomedical is a research and development company that advances drug discovery and development for the prevention, inhibition, and treatment of neurological, oncology and immuno-related diseases. The company is based in Rochester, NY.... Read More
